High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene - PubMed (original) (raw)
. 2001 Jul 27;310(5):1167-76.
doi: 10.1006/jmbi.2001.4816.
Affiliations
- PMID: 11502003
- DOI: 10.1006/jmbi.2001.4816
High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene
R C Hillig et al. J Mol Biol. 2001.
Abstract
The heterotrimeric complex of the human major histocompatibity complex (MHC) molecule HLA-A*0201, beta2-microglobulin and the decameric peptide GVYDGREHTV derived from the melanoma antigen (MAGE-A4 protein has been determined by X-ray crystallography at 1.4 A resolution. MAGE-A4 belongs to a family of genes that are specifically expressed in a variety of tumours. MAGE-A4-derived peptides are presented by MHC molecules at the cell surface to cytotoxic T-lymphocytes. As the HLA-A*0201:MAGE-A4 complex occurs only on tumour cells, it is considered to be an appropriate target for immunotherapy. The structure presented here reveals potential epitopes specific to the complex and indicates which peptide residues could be recognised by T-cell receptors. In addition, as the structure could be refined anisotropically, it was possible to describe the movements of the bound peptide in more detail.
Similar articles
- Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.
Tahara K, Takesako K, Sette A, Celis E, Kitano S, Akiyoshi T. Tahara K, et al. Clin Cancer Res. 1999 Aug;5(8):2236-41. Clin Cancer Res. 1999. PMID: 10473111 - Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
Neumann F, Sturm C, Hülsmeyer M, Dauth N, Guillaume P, Luescher IF, Pfreundschuh M, Held G. Neumann F, et al. Immunol Lett. 2009 Aug 15;125(2):86-92. doi: 10.1016/j.imlet.2009.06.002. Epub 2009 Jun 12. Immunol Lett. 2009. PMID: 19524620 - Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
Akiyama Y, Maruyama K, Tai S, Komiyama M, Iizuka A, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K. Akiyama Y, et al. Anticancer Res. 2009 Feb;29(2):647-55. Anticancer Res. 2009. PMID: 19331215 - The potential of melanoma antigen expression in cancer therapy.
Gillespie AM, Coleman RE. Gillespie AM, et al. Cancer Treat Rev. 1999 Aug;25(4):219-27. doi: 10.1053/ctrv.1999.0126. Cancer Treat Rev. 1999. PMID: 10448130 Review. - Outsize peptides bulge out of the groove.
Thorpe CJ. Thorpe CJ. Immunol Today. 1993 Feb;14(2):51-2. doi: 10.1016/0167-5699(93)90057-r. Immunol Today. 1993. PMID: 8447932 Review.
Cited by
- T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4.
Coles CH, McMurran C, Lloyd A, Hock M, Hibbert L, Raman MCC, Hayes C, Lupardus P, Cole DK, Harper S. Coles CH, et al. J Biol Chem. 2020 Aug 14;295(33):11486-11494. doi: 10.1074/jbc.RA120.014016. Epub 2020 Jun 12. J Biol Chem. 2020. PMID: 32532817 Free PMC article. - Mimicking the germinal center reaction in hybridoma cells to isolate temperature-selective anti-PEG antibodies.
Su YC, Al-Qaisi TS, Tung HY, Cheng TL, Chuang KH, Chen BM, Roffler SR. Su YC, et al. MAbs. 2014 Jul-Aug;6(4):1069-83. doi: 10.4161/mabs.29124. Epub 2014 May 14. MAbs. 2014. PMID: 24874693 Free PMC article. - Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.
Zacharias M, Springer S. Zacharias M, et al. Biophys J. 2004 Oct;87(4):2203-14. doi: 10.1529/biophysj.104.044743. Biophys J. 2004. PMID: 15454423 Free PMC article. - Evolutionary history of the cancer immunity antigen MAGE gene family.
Katsura Y, Satta Y. Katsura Y, et al. PLoS One. 2011;6(6):e20365. doi: 10.1371/journal.pone.0020365. Epub 2011 Jun 10. PLoS One. 2011. PMID: 21695252 Free PMC article. - Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities.
Armstrong KM, Insaidoo FK, Baker BM. Armstrong KM, et al. J Mol Recognit. 2008 Jul-Aug;21(4):275-87. doi: 10.1002/jmr.896. J Mol Recognit. 2008. PMID: 18496839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials